We are live on !
Find out more
Winton Group Portfolio holdings
AUM
$3.09B
Turnover
59.06%
1-Year Est. Return
40.4%
This Fund
S&P 500
This Quarter Est. Return
+21.95%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.71%
AUM
$1.39B
AUM Growth
-$1.69B
(-55%)
Cap. Flow
-$2.06B
Cap. Flow % of AUM
Cap. Flow %
-148.56%
Top 10 Holdings %
Top 10 Hldgs %
17%
Holding
1,625
New
174
Increased
68
Reduced
1,053
Closed
325
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.4M |
| 2 |
Rollins
ROL
|
+$7.74M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$6.09M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$4.85M |
| 5 |
Stifel
SF
|
+$3.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$18.2M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$13.5M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$13.1M |
| 4 |
Kimberly-Clark
KMB
|
+$12.5M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.92% |
| 2 | Healthcare | 13.35% |
| 3 | Consumer Discretionary | 13.25% |
| 4 | Technology | 12.04% |
| 5 | Industrials | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TREC
1276
DELISTED
Trecora Resources
TREC
| $71K | 0.01% |
10,201
-23,231
| -69% | -$156K |
2019 Q3
5 quarters
|
|
1277
Oramed Pharmaceuticals
ORMP
$169M
| $69K | 0.01% |
16,375
-11,963
| -42% | -$38.9K |
2020 Q3
1 quarter
|
|
|
FNHC
1278
DELISTED
FedNat Holding Company Common Stock
FNHC
| $66K | ﹤0.01% |
11,205
-14,751
| -57% | -$84.2K |
2020 Q2
2 quarters
|
|
1279
DELISTED
Assertio
ASRT
| $64K | ﹤0.01% |
2,973
-2,254
| -43% | -$70.1K |
2019 Q4
4 quarters
|
|
|
NBRV
1280
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $64K | ﹤0.01% |
1,054
-1,481
| -58% | -$160K |
2020 Q2
2 quarters
|
|
1281
Lineage Cell Therapeutics
LCTX
$247M
| $61K | ﹤0.01% |
34,771
-32,761
| -49% | -$45.8K |
2019 Q4
4 quarters
|
|
1282
DELISTED
CASI Pharmaceuticals
CASI
| $58K | ﹤0.01% |
1,980
-5,703
| -74% | -$124K |
2019 Q3
5 quarters
|
|
1283
Corbus Pharmaceuticals
CRBP
$87.4M
| $58K | ﹤0.01% |
+1,558
| New | +$58.2K |
2020 Q4
0 quarters
|
|
|
STSA
1284
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $55K | ﹤0.01% |
+11,911
| New | +$51.3K |
2020 Q4
0 quarters
|
|
1285
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $54K | ﹤0.01% |
798
-5,699
| -88% | -$776K |
2019 Q3
5 quarters
|
|
1286
Ramaco Resources Class A
METC
$499M
| $53K | ﹤0.01% |
19,167
+2,497
| +15% | +$7.58K |
2020 Q2
2 quarters
|
|
1287
Verastem
VSTM
$783M
| $53K | ﹤0.01% |
+2,056
| New | +$41.3K |
2020 Q4
0 quarters
|
|
1288
Geron
GERN
$752M
| $47K | ﹤0.01% |
29,513
-41,083
| -58% | -$74.8K |
2020 Q2
2 quarters
|
|
|
AXAS
1289
DELISTED
Abraxas Petroleum Corp
AXAS
| $47K | ﹤0.01% |
20,431
-3,521
| -15% | -$8.23K |
2019 Q4
4 quarters
|
|
1290
DELISTED
Nine Energy Service
NINE
| $46K | ﹤0.01% |
17,029
-18,166
| -52% | -$33.4K |
2020 Q2
2 quarters
|
|
1291
Pulmatrix
PULM
$4.97M
| $44K | ﹤0.01% |
1,856
-69
| -4% | -$1.64K |
2020 Q3
1 quarter
|
|
|
EMAN
1292
DELISTED
eMagin Corporation
EMAN
| $41K | ﹤0.01% |
+24,933
| New | +$32K |
2020 Q4
0 quarters
|
|
1293
DELISTED
PHX Minerals
PHX
| $39K | ﹤0.01% |
16,818
-21,070
| -56% | -$38.2K |
2019 Q3
5 quarters
|
|
|
ZSAN
1294
DELISTED
Zosano Pharma Corporation
ZSAN
| $35K | ﹤0.01% |
1,911
-1,523
| -44% | -$29.8K |
2020 Q2
2 quarters
|
|
1295
Senseonics Holdings Inc
SENS
$411M
| $21K | ﹤0.01% |
1,206
-503
| -29% | -$4.38K |
2020 Q3
1 quarter
|
|
1296
iBio
IBIO
$49.3M
| $18K | ﹤0.01% |
34
-28
| -45% | -$22.8K |
2020 Q2
2 quarters
|
|
1297
DELISTED
Genesis Healthcare, Inc.
GEN
| $18K | ﹤0.01% |
36,159
+8,468
| +31% | +$4.28K |
2020 Q3
1 quarter
|
|
1298
American Assets Trust
AAT
$1.31B
| – | – |
-46,901
| Closed | -$1.13M | – |
|
1299
Asbury Automotive
ABG
$3.05B
| – | – |
-3,645
| Closed | -$355K | – |
|
1300
Arbor Realty Trust
ABR
$502M
| – | – |
-45,160
| Closed | -$518K | – |
|
Similar funds
HC
Winton Group's Q4 2020 Portfolio in Review
As of Q4 2020, Winton Group held 1,625 positions worth $1.39B, down 55% from $3.08B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Winton Group withdrew a net $2.06B in Q4 2020, closing 325 positions and reducing 1,053 holdings. Its most notable exit was Immunomedics Inc, an estimated $8.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Winton Group opened a new position in Stifel worth $4.52M.
- Winton Group's largest Q4 2020 buy was Stifel: 134,360 shares worth $4.52M.
- Winton Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2020, an estimated $12.4M increase.
- Winton Group's biggest Q4 2020 reduction was Edwards Lifesciences, cutting an estimated $18.2M.
- Winton Group fully exited Immunomedics Inc in Q4 2020, selling an estimated $8.1M.
- Winton Group's ten largest holdings make up 17% of its $1.39B portfolio in Q4 2020.
- Winton Group opened 174 new positions and closed 325 in Q4 2020.
- Winton Group's portfolio value fell 55% quarter-over-quarter to $1.39B.
Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.